Skip to main content
. Author manuscript; available in PMC: 2022 Oct 1.
Published in final edited form as: J Comp Pathol. 2021 Aug 27;188:1–12. doi: 10.1016/j.jcpa.2021.07.006

Fig. 6.

Fig. 6.

Kaplan–Meier product-limit estimates for 24 dogs diagnosed with splenic sarcoma from complex nodular hyperplasia (CNH) and undifferentiated stromal sarcoma (SS) grouped by mitotic count (<9 per 10 HPFs, solid line; >9 per 10 HPFs, dotted line). Probability of survival (%). HR, hazard ratio.